Globe Life (NYSE:GL) Stock Price Down 6.3% Following Analyst Downgrade

Posted by Geri Gentry on Oct 23rd, 2026

Globe Life Inc. (NYSE:GL – Get Free Report) shares were down 6.3% on Friday after TD Cowen lowered their price target on the stock from $225.00 to $215.00. TD Cowen currently has a buy rating on the stock. Globe Life traded as low as $159.45 and last traded at $157.7170. 274,396 shares changed hands during trading, a decline of 49% from the average session volume of 540,886 shares. The stock had previously closed at $168.41.

A number of other research firms also recently commented on GL. Jefferies Financial Group boosted their price target on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research note on Friday, July 10th. UBS Group set a $165.00 target price on shares of Globe Life in a report on Friday. Piper Sandler lowered Globe Life from an “overweight” rating to a “neutral” rating and set a $165.00 price objective on the stock. in a research note on Friday. JPMorgan Chase & Co. lifted their target price on Globe Life from $193.00 to $195.00 and gave the stock an “overweight” rating in a report on Thursday, October 15th. Finally, Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and a consensus target price of $182.60.

Get Our Latest Stock Analysis on Globe Life

Insider Buying and Selling

In related news, CFO Thomas Kalmbach sold 21,000 shares of Globe Life stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total transaction of $3,781,260.00. Following the completion of the sale, the chief financial officer owned 50,568 shares of the company’s stock, valued at approximately $9,105,274.08. This trade represents a 29.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Majors sold 37,000 shares of the firm’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the transaction, the executive vice president directly owned 53,518 shares in the company, valued at approximately $9,560,455.52. This represents a 40.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 143,650 shares of company stock worth $25,793,717. Company insiders own 2.11% of the company’s stock.

Trending Headlines about Globe Life

Here are the key news stories impacting Globe Life this week:

Positive Sentiment: Globe Life reported third-quarter revenue of approximately $1.60 billion, above the $1.56 billion analyst consensus, with revenue up 5.5% year over year. Operating EPS increased to $4.84 from $4.81 a year earlier. Globe Life third-quarter 2026 results
Positive Sentiment: Management is targeting $850 million to $950 million in parent excess cash flow for 2027, which could support capital returns, debt reduction or other shareholder-friendly actions. The company projects 2027 EPS of $16.10 to $17.10, a range that includes the $16.51 consensus estimate. Globe Life 2027 outlook
Neutral Sentiment: The company’s 2027 EPS guidance of $16.10 to $17.10 implies continued earnings growth, but the broad range suggests uncertainty around operating performance and future underwriting results.
Negative Sentiment: Third-quarter operating EPS of $4.84 missed estimates ranging from $4.87 to $4.90. Weaker underwriting income and higher expenses offset gains from increased premiums and investment income. Globe Life Q3 earnings miss
Negative Sentiment: Globe Life cut its FY 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Reports also cited losses at Evry Health as a factor pressuring the full-year guidance. Evry Health losses and Globe Life guidance
Negative Sentiment: The quarter included a reported underwriting loss of about $6.4 million, raising investor concerns about claims trends, expense control and the company’s ability to convert premium growth into profits. Globe Life underwriting loss analysis

Institutional Trading of Globe Life

Several institutional investors and hedge funds have recently bought and sold shares of the business. Johnson Financial Group Inc. purchased a new position in shares of Globe Life in the second quarter valued at approximately $39,000. AdvisorNet Financial Inc increased its position in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares during the period. Fortitude Family Office LLC grew its stake in shares of Globe Life by 94.6% during the 3rd quarter. Fortitude Family Office LLC now owns 327 shares of the company’s stock worth $54,000 after purchasing an additional 159 shares during the period. Hilton Head Capital Partners LLC increased its stake in shares of Globe Life by 55.4% during the 1st quarter. Hilton Head Capital Partners LLC now owns 331 shares of the company’s stock worth $46,000 after purchasing an additional 118 shares in the last quarter. Finally, Assetmark Inc. lifted its holdings in shares of Globe Life by 42.0% during the 2nd quarter. Assetmark Inc. now owns 426 shares of the company’s stock worth $76,000 after acquiring an additional 126 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Down 6.4%

The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $12.11 billion, a PE ratio of 10.47 and a beta of 0.44. The firm has a 50-day simple moving average of $170.48 and a 200 day simple moving average of $167.25.

Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings results on Wednesday, October 21st. The company reported $4.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.90 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $4.81 EPS. On average, research analysts predict that Globe Life Inc. will post 15.70 EPS for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. Globe Life’s payout ratio is currently 8.76%.

Globe Life announced that its Board of Directors has approved a stock repurchase program on Monday, August 10th that allows the company to repurchase $2.50 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 17.7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its shares are undervalued.

About Globe Life

(Get Free Report)

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.